Vyant Bio, Inc. - stock earnings
Stock symbol VYNT is outdated, potentially delisted? Maybe it is available on other exchange?
VYNT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -1.6 million USD | 119000 USD |
| 2023Q1 | ? USD | 80000 USD |
| 2022Q4 | -10.3 million USD | 46000 USD |
| 2022Q3 | -3.5 million USD | 152000 USD |
| 2022Q2 | -5.8 million USD | 165000 USD |
| 2022Q1 | -9.2 million USD | 303000 USD |
| 2021Q4 | -2.6 million USD | -2.5 million USD |
| 2021Q3 | -4.5 million USD | 1.5 million USD |
| 2021Q2 | -4.2 million USD | 1.9 million USD |
| 2021Q1 | -7.4 million USD | 222000 USD |
| 2020Q4 | -2.4 million USD | 265000 USD |
| 2020Q3 | -3.0 million USD | 335000 USD |
| 2020Q2 | -1.3 million USD | 99000 USD |
| 2020Q1 | -2.0 million USD | 168000 USD |
| 2019Q4 | -293000 USD | 1.9 million USD |
| 2019Q3 | 2.0 million USD | 2.1 million USD |
| 2019Q2 | -3.8 million USD | 1.5 million USD |
| 2019Q1 | -3.8 million USD | 6.8 million USD |
| 2018Q4 | -3.8 million USD | 6.8 million USD |
| 2018Q3 | -8.5 million USD | 5.9 million USD |
| 2018Q2 | -3.6 million USD | 7.0 million USD |
| 2018Q1 | -7.9 million USD | 7.5 million USD |
| 2017Q4 | -7.9 million USD | 7.5 million USD |
| 2017Q3 | -633000 USD | 8.0 million USD |
| 2017Q2 | -2.8 million USD | 6.6 million USD |
| 2017Q1 | -9.6 million USD | 7.0 million USD |
| 2016Q4 | -2.8 million USD | 7.2 million USD |
| 2016Q3 | -3.7 million USD | 6.8 million USD |
| 2016Q2 | -4.0 million USD | 7.0 million USD |
| 2016Q1 | -5.3 million USD | 6.1 million USD |
| 2015Q4 | -5.7 million USD | 5.5 million USD |
| 2015Q3 | -5.2 million USD | 4.0 million USD |
| 2015Q2 | -5.0 million USD | 4.2 million USD |
| 2015Q1 | -4.3 million USD | 4.4 million USD |
| 2014Q4 | -5.2 million USD | 4.0 million USD |
| 2014Q3 | -4.8 million USD | 3.2 million USD |
| 2014Q2 | -4.2 million USD | 1.5 million USD |
| 2014Q1 | -2.5 million USD | 1.4 million USD |
| 2013Q4 | -2.5 million USD | 1.9 million USD |
| 2013Q3 | -3.1 million USD | 1.7 million USD |
| 2013Q2 | -9.1 million USD | 1.8 million USD |
| 2013Q1 | 2.4 million USD | 1.2 million USD |
| 2012Q3 | 311588 USD | 1.2 million USD |
| 2012Q2 | -1.9 million USD | 1.1 million USD |
| 2012Q1 | -1.1 million USD | 834752 USD |
| 2011Q1 | -9.1 million USD | 825144 USD |
VYNT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -22.7 million USD | 666000 USD |
| 2021 | -40.9 million USD | 1.1 million USD |
| 2020 | -8.7 million USD | 867000 USD |
| 2019 | -9.0 million USD | 605000 USD |
| 2018 | -8.4 million USD | 618000 USD |
| 2017 | -20.9 million USD | 29.1 million USD |
| 2016 | -15.8 million USD | 27.0 million USD |
| 2015 | -20.2 million USD | 18.0 million USD |
| 2014 | -16.6 million USD | 10.2 million USD |
| 2013 | -12.4 million USD | 6.6 million USD |
| 2012 | -6.7 million USD | 4.3 million USD |
| 2011 | -19.9 million USD | 3.0 million USD |
| 2010 | -8.4 million USD | 2.5 million USD |
| 2009 | -7.3 million USD | 1.7 million USD |
VYNT
Price: $0.19
52 week price:
Earnings Per Share: -2.19 USD
P/E Ratio: 0.65
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 46200
Market Capitalization: 1.2 million